Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: The LITHE Study 2-year results - Fleischmann, R M; Halland, A M; Brzosko, M (J Rheumatol, 2013)
et al.